Showing results (841-850 of 871) with videos related to
Sort By:
Pageof 88
PNAS Nexus|January 30, 2023
Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areataJerry Tsai, Sadakatali Gori, Jesse Alt, et al.Journal of Clinical Medicine|June 26, 2026
Risk Factor Levels and the Burden of Skin Melanoma in Poland with Predictions Regarding the 2020-2030 PerspectiveSławomir Porada, Aleksandra Czerw, Grażyna Dykowska, et al.Microbial Genomics|January 27, 2026
Optimizing data-driven excellence: Canada's approach to using pathogen test datasets for quality control, pipeline development and training initiativesKara D Loos, Mark Horsman, Jeff Tuff, et al.Biology Letters|May 14, 2010
Canopy and litter ant assemblages share similar climate-species density relationshipsMichael D Weiser, Nathan J Sanders, Donat Agosti, et al.Cancer Cell|August 10, 2021
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunityJoseph M Gozgit, Melissa M Vasbinder, Ryan P Abo, et al.Ecology Letters|March 19, 2009
Climatic drivers of hemispheric asymmetry in global patterns of ant species richnessRobert R Dunn, Donat Agosti, Alan N Andersen, et al.Science Immunology|January 11, 2024
UNC93B1 variants underlie TLR7-dependent autoimmunityChristine Wolf, Ee Lyn Lim, Mohammad Mokhtari, et al.Plos One|June 2, 2018
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferationMichael J Thomenius, Jennifer Totman, Darren Harvey, et al.Nature Chemical Biology|April 28, 2015
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL modelsElayne Chan-Penebre, Kristy G Kuplast, Christina R Majer, et al.Nature Genetics|November 27, 2004
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatmentElisabeth B Binder, Daria Salyakina, Peter Lichtner, et al.Pageof 88